Research Nester published a report titled “Human Microbiome Market: Global Demand Analysis & Opportunity Outlook 2031” which delivers detailed overview of the global human microbiome market in terms of market segmentation by product, disease type, organism type, application, technology, and by region.

Further, for the in-depth analysis, the report encompasses the industry growth indicators, restraints, supply and demand risk, along with detailed discussion on current and future market trends that are associated with the growth of the market.

The global human microbiome market is anticipated to grow with a CAGR of 22.3% over the forecast period, i.e., 2022 – 2031. The market is segmented by product into probiotics, prebiotics, diagnostic tests, drugs, and others, out of which, the probiotics segment is anticipated to garner the largest revenue of USD 1427.7 Million by the end of 2031. Additionally, in the year 2021, the segment generated a revenue of USD 187.2 Million.

The global human microbiome market is estimated to garner a revenue of USD 3251.4 Million by the end of 2031, up from a revenue of USD 438.3 Million in the year 2021. Increasing prevalence of lifestyle-related diseases, followed by the growing focus on microbiome therapeutics to drive the growth of the market in the coming years.

Geographically, the global human microbiome market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. Out of these, the market in North America is anticipated to garner the largest revenue of USD 1859.8 Million by the end of 2031. Additionally, in the year 2021, the market in the region generated a revenue of USD 251.6 Million.

The research is global in nature and covers detailed analysis on the market in North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC [Finland, Sweden, Norway, Denmark], Poland, Turkey, Russia, Rest of Europe), Latin America (Brazil, Mexico, Argentina, Rest of Latin America), Asia-Pacific (China, India, Japan, South Korea, Indonesia, Singapore, Malaysia, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of Middle East and Africa). In addition, analysis comprising market size, Y-O-Y growth & opportunity analysis, market players’ competitive study, investment opportunities, demand for future outlook etc. has also been covered and displayed in the research report.

Growing Research and Developments on Human Microbiome to Create Opportunities for Market Growth

The first phase of the Human Microbiome Project (HMP) was launched by the National Institutes of Health (NIH) of the United States in the year 2007. This was majorly done to improve the understanding of the microbiota involved in human health and disease. Additionally, the second phase of the study, which was known as the Integrative Human Microbiome Project (iHMP), was launched in the year 2014 with an aim to generate resources to characterize the microbiome. The surge in focus of the government of nations worldwide to study the human microbiome is therefore anticipated to drive the growth of the market in the coming years.

However, the stringent government regulations is expected to operate as key restraint to the growth of global human microbiome market over the forecast period.

This report also provides the existing competitive scenario of some of the key players of the global human microbiome market which includes company profiling of Seres Therapeutics, Inc., Evelo Biosciences, Inc., Synlogic, SECOND GENOME, Synthetic Biologics, Inc., YSOPIA Bioscience, 4D pharma plc, DuPont de Nemours, Inc., BiomX Inc., Sun Genomics, Inc., Viome Life Sciences, Inc., and others. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global human microbiome market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.